Correlation between oxidation potentials and inhibitory effects on Epstein-Barr virus activation of flavonoids

被引：15

作者：

Koyama, Junko ^{[1
]}

Morita, Izumi ^{[1
]}

Kobayashi, Norihiro ^{[1
]}

Konoshima, Takao ^{[2
]}

Takasaki, Midori ^{[2
]}

Osakai, Toshiyuki ^{[3
]}

Tokuda, Harukuni ^{[4
]}

机构：

[1] Kobe Pharmaceut Univ, Fac Pharmaceut Sci, Higashinada Ku, Kobe, Hyogo 6588558, Japan

[2] Chiba Inst Sci, Fac Pharmaceut Sci, Choshi 2880025, Japan

[3] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan

[4] Kyoto Prefectural Univ Med, Dept Mol Biochem, Kyoto 6020841, Japan

来源：

CANCER LETTERS | 2008年 / 263卷 / 01期

关键词：

oxidation potential; flavonoid; Epstein-Barr virus early antigen; cyclic voltammetry;

D O I：

10.1016/j.canlet.2007.12.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The oxidation potentials of fifteen flavonoids in phosphate buffer at pH 7.2 were determined by cyclic voltammetry. A good correlation was found between these oxidation potentials and the ability of flavonoids to inhibit Epstein-Barr virus early antigen (EBV-EA) activation. Furthermore, multiple regression analysis revealed that the solvent-accessible surface area (SASA) was a useful parameter for estimating the inhibitory effects of flavonoids on EBV-EA activation. (C) 2007 Elsevier Ireland Ltd. All rights reserved.

引用

页码：61 / 66

页数：6

共 50 条

[1] Inhibitory effects on Epstein-Barr virus activation of anthraquinones: Correlation with redox potentials
Koyama, J
Tagahara, K
Osakai, T
Tsujino, Y
Tsurumi, S
Nishino, H
Tokuda, H
[J]. CANCER LETTERS, 1997, 115 (02) : 179 - 183
[2] Correlation with redox potentials and inhibitory effects on Epstein-Barr virus activation of azaanthraquinones
Koyama, J
Morita, I
Tagahara, K
Osakai, T
Hotta, H
Yang, MX
Mukainaka, T
Nishino, H
Tokuda, H
[J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (09) : 1214 - 1216
[3] Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation by emodin derivatives
Koyama, Junko
Inoue, Munetaka
Morita, Izumi
Kobayashi, Norihiro
Osakai, Toshiyuki
Nishino, Hoyoku
Tokuda, Harukuni
[J]. CANCER LETTERS, 2006, 241 (02) : 263 - 267
[4] Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation of poly-substituted anthraquinones
Koyama, J
Morita, I
Kobayashi, N
Osakai, T
Nishino, H
Tokuda, H
[J]. CANCER LETTERS, 2005, 225 (02) : 193 - 198
[5] Correlation of redox potentials and inhibitory effects on Epstein-Barr virus activation of 2-azaanthraquinones
Koyama, J
Morita, I
Kobayashi, N
Osakai, T
Hotta, H
Takayasu, J
Nishino, H
Tokuda, H
[J]. CANCER LETTERS, 2004, 212 (01) : 1 - 6
[6] Correlation between reduction potentials and inhibitions of Epstein-Barr virus activation by anthraquinone derivatives
Koyama, Junko
Nisino, Yu
Morita, Izumi
Kobayashi, Norihiro
Osakai, Toshiyuki
Tokuda, Harukuni
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4106 - 4109
[7] Inhibitory effects of lapachol derivatives on Epstein-Barr virus activation
Sacau, EP
Estévez-Braun, A
Ravelo, AG
Ferro, EA
Tokuda, H
Mukainaka, T
Nishino, H
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (04) : 483 - 488
[8] Inhibitory effects of anthraquinones and bianthraquinones on Epstein-Barr virus activation
Koyama, J
Morita, I
Tagahara, K
Ogata, M
Mukainaka, T
Tokuda, H
Nishino, H
[J]. CANCER LETTERS, 2001, 170 (01) : 15 - 18
[9] Inhibitory effects of lantadenes and related triterpenoids on Epstein-Barr virus activation
Inada, A
Nakanishi, T
Tokuda, H
Nishina, H
Iwashima, A
Sharma, OP
[J]. PLANTA MEDICA, 1995, 61 (06) : 558 - 559
[10] Inhibitory effects of quassinoid derivatives on Epstein-Barr virus early antigen activation
Rahman, S
Fukamiya, N
Ohno, N
Tokuda, H
Nishino, H
Tagahara, K
Lee, KH
Okano, M
[J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1997, 45 (04) : 675 - 677

← 1 2 3 4 5 →